SCHEMBL20069601

SCHEMBL20069601

CC(O)CC(=O)NC1(Cc2ccccc2)CCN(C)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.49
ALDH1A1 P00352 2/20 0.48
ADRB2 P07550 2/20 0.48
HTT P42858 1/20 0.48
RET P07949 1/20 0.47
CTSL P07711 1/20 0.47
CTSS P25774 1/20 0.47
CTSK P43235 1/20 0.47
SCN1A P35498 2/20 0.42
SCN2A Q99250 2/20 0.42
SCN3A Q9NY46 2/20 0.42
HSD17B10 Q99714 1/20 0.41
NPFFR1 Q9GZQ6 1/20 0.41
NPFFR2 Q9Y5X5 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KDM4E B2RXH2 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
P2RX7 Q99572 1/20 0.38
CHRM1 P11229 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205886 0.89 DPP4 (0.48) DPP4ALDH1A1ADRB2HTTRET
SCHEMBL20147384 0.89 DPP4 (0.48) DPP4ALDH1A1ADRB2HTTRET
SCHEMBL25502319 0.88 DPP4 (0.50) DPP4ALDH1A1ADRB2HTTRET
SCHEMBL20158744 0.87 DPP4 (0.47) DPP4ALDH1A1ADRB2HTTRET
SCHEMBL20069608 0.84 ADRB2 (0.49) DPP4ALDH1A1ADRB2HTTRET
SCHEMBL20069533 0.82 ADRB2 (0.47) DPP4ALDH1A1ADRB2HTTRET
SCHEMBL20069529 0.81 ALDH1A1 (0.45) DPP4ALDH1A1ADRB2HTTRET
SCHEMBL20069607 0.81 ADRB2 (0.46) DPP4ALDH1A1ADRB2HTTRET
SCHEMBL20068812 0.81 RET (0.48) DPP4ALDH1A1ADRB2HTTRET
SCHEMBL20069536 0.80 RET (0.47) DPP4ALDH1A1ADRB2HTTRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018071454-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ANDREWS STEVEN W (US) 2018-04-19 WO disclosed